-
Posted: June 5th, 2024, 11:00pm UTC
Conditions: Gastrointestinal Disease
Interventions: Procedure: Radical operation and perioperative therapy
Sponsors: Nanfang Hospital, Southern Medical University
Not yet recruiting
-
Posted: March 27th, 2024, 11:00pm UTC
Conditions: Pancreatic Adenocarcinoma; Ampulla of Vater Carcinoma; Adrenocortical Carcinoma; Neuroendocrine Carcinoma; Soft Tissue Sarcoma; Small Bowel Adenocarcinoma; Duodenum Adenocarcinoma; Gastric Adenocarcinoma
Interventions: Drug: Dostarlimab; Drug: Chemotherapy
Sponsors: UNICANCER; National Cancer Institute, France; GlaxoSmithKline
Recruiting
-
Posted: March 21st, 2024, 11:00pm UTC
Conditions: Pancreaticoduodenectomy
Interventions: Procedure: Main pancreatic duct and biliary duct external drainage; Procedure: Main pancreatic duct and biliary duct internal drainage
Sponsors: Shanghai Zhongshan Hospital; Huadong Hospital; RenJi Hospital; The First People's Hospital of Yunnan; First Affiliated Hospital Xi'an Jiaotong University; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Recruiting
-
Posted: September 30th, 2022, 11:00pm UTC
Conditions: Gastric Outlet Obstruction
Interventions: Procedure: Surgical gastrojejunostomy (SGJ); Procedure: Endoscopic gastrojejunostomy (EGJ)
Sponsors: Northwell Health
Recruiting
-
Posted: June 18th, 2021, 11:00pm UTC
Conditions: Metastatic Cancer; Foregut Carcinoid Tumor; Gastric Adenocarcinoma; Gallbladder Adenocarcinoma; Liver Cancer; GI Cancer; GI Carcinoma; Lung Cancer
Interventions: Drug: Standard of Care Chemotherapy; Procedure: Video-Assisted Thoracic Surgery (VATS); Procedure: Lobectomy; Radiation: Consolidative Radiation; Radiation: Ablation Treatment; Procedure: Resection or Excision; Procedure: Peritonectomy; Other: Transarterial Radioembolization
Sponsors: University of Chicago
Withdrawn
-
Posted: June 1st, 2021, 11:00pm UTC
Conditions: Advanced Solid Tumours
Interventions: Drug: RXC004; Drug: RXC004; Drug: RXC004; Biological: Denosumab; Biological: pembrolizumab
Sponsors: Redx Pharma Plc; Merck Sharp & Dohme LLC
Completed
-
Posted: February 21st, 2021, 1:00am UTC
Conditions: Pancreatic Cancer; Bile Duct Cancer; Ampulla of Vater Cancer
Interventions: Procedure: pancreaticoduodenectomy
Sponsors: State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital
Active, not recruiting
-
Posted: November 21st, 2019, 1:00am UTC
Conditions: Pancreaticoduodenectomy
Interventions: Procedure: robotic pancreaticoduodenectomy
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Recruiting
-
Posted: January 23rd, 2019, 1:00am UTC
Conditions: Pancreatic Cancer
Interventions: Procedure: Whipples pancreatico-duodenectomy
Sponsors: University of Edinburgh; NHS Lothian
Completed
-
Posted: May 2nd, 2016, 11:00pm UTC
Conditions: Acinar Cell Carcinoma; Ampulla of Vater Adenocarcinoma; Cholangiocarcinoma; Duodenal Adenocarcinoma; Pancreatic Adenocarcinoma; Pancreatic Ductal Adenocarcinoma; Pancreatic Intraductal Papillary Mucinous Neoplasm; Periampullary Adenocarcinoma
Interventions: Procedure: Pancreatectomy; Other: Lavage; Procedure: Pancreatectomy; Other: Lavage; Procedure: Pancreatectomy
Sponsors: Sidney Kimmel Cancer Center at Thomas Jefferson University
Recruiting
-
Posted: December 3rd, 2014, 1:00am UTC
Conditions: Adenoma, Villous
Interventions: Procedure: Endoscopic Mucosal Resection
Sponsors: Professor Michael Bourke
Recruiting
-
Posted: December 3rd, 2013, 1:00am UTC
Conditions: Pancreas Cancer; Peutz-Jeghers Syndrome (PJS); Gene Mutation; Germline Mutation Carrier; Lynch Syndrome
Interventions: Drug: Secretin; Diagnostic Test: MRI; Other: Tumor marker gene test with CA19-9
Sponsors: Johns Hopkins University; ChiRhoClin, Inc.; National Cancer Institute (NCI); National Institutes of Health (NIH)
Recruiting
-
Posted: April 5th, 2013, 11:00pm UTC
Conditions: Ampulla of Vater Adenocarcinoma; Gallbladder Adenocarcinoma; Metastatic Pancreatic Adenocarcinoma; Pancreatic Adenocarcinoma; Stage III Ampulla of Vater Cancer; Stage III Intrahepatic Cholangiocarcinoma; Stage III Pancreatic Cancer; Stage IIIA Gallbladder Cancer; Stage IIIA Hilar Cholangiocarcinoma; Stage IIIB Gallbladder Cancer; Stage IIIB Hilar Cholangiocarcinoma; Stage IV Ampulla of Vater Cancer; Stage IVA Gallbladder Cancer; Stage IVA Hilar Cholangiocarcinoma; Stage IVA Intrahepatic Cholangiocarcinoma; Stage IVA Pancreatic Cancer; Stage IVB Gallbladder Cancer; Stage IVB Hilar Cholangiocarcinoma; Stage IVB Intrahepatic Cholangiocarcinoma; Stage IVB Pancreatic Cancer
Interventions: Drug: ADH-1; Drug: Cisplatin; Drug: Gemcitabine Hydrochloride; Other: Laboratory Biomarker Analysis
Sponsors: University of Nebraska; Adherex Technologies, Inc.; National Cancer Institute (NCI)
Completed